Biosimilars
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Biosimilars
Navigating Uncertainty in Biosimilar Drug Development
Bryan Katz of Syneos Health and Brittany Scott of Addison Whitney share insights from DIABryan Katz, Vice President Integrated Solutions, Syneos Health and Brittany Scott, Creative Director, Addison Whitney, a Syneos Health company 07.11.18
-
Bio News | Biosimilars | Collaborations & Alliances | Drug Development | Industry News
Prestige BioPharma, Alvogen Enter Agreement
For the exclusive partnership and supply for the commercialization of Prestige BioPharma´s Trastuzumab biosimilar in Europe07.02.18
-
Bio News | Biosimilars | Breaking News | Industry News
Oncobiologics Enters First CDMO Contract
Officially launches BioSymphony Platform-based CDMO business06.18.18
-
Bio News | Biosimilars | Drug Development | Industry News
SGS Continues to Lead in Comparability Services
Business development manager Nicole Kovacs shares insight on SGS life sciences division's servicesVideos
-
Biologics, Proteins, Vaccines | Biosimilars
Biogenerics Progress
Generic makers target big forays into major marketsS. Harachand, Contributing Editor 06.12.18
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
Beactica Signs Three-Year Extension Agreement With Sanofi
Results from the collaboration contributed towards approval of Insulin lispro06.01.18
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
mAbxience, Amneal Enter Biosimilar Tie-up
Agreement will bring a biosimilar of bevacizumab to the U.S.05.23.18
-
Bio News | Biosimilars | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
Catalent, Valerius Enter Biosimilars Collaboration
Catalent Biologics to provide cell line development and support cGMP manufacturing05.14.18
-
Biologics, Proteins, Vaccines | Biosimilars
Biopharma Manufacturing Markets
Biomanufacturing contract services and supplies markets continue to expandRonald A. Rader and Eric S. Langer, BioPlan Associates 05.08.18
-
Biologics, Proteins, Vaccines | Biosimilars
Contract BioManufacturing in China: Creating a New Segment
An up-close look at China’s growing market for CMO services.Vicky Qing Xia and Leo Cai Yang, BioPlan Associates 04.10.18
-
Bio News | Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | Industry News
BioPlan Associates' 15th Annual Bio Mfg. Study is Open
Participate and get a FREE aggregated summary of this year's results02.16.18
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | R&D
Sandoz & Biocon Enter Global Partnership
To develop and commercialize biosimilars in immunology and oncology01.23.18
-
Biosimilars | Trials & Filings
Amgen, Allergan MVASI Biosimilar Wins EC Approval
Becomes first biosimilar bevacizumab approved by the EC for the treatment of certain types of cancers01.19.18
-
Aseptic Processing | Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | Facilities | Fill/Finish | Industry News
New Aseptic Fill/Finish CMO Launches Operations
Wuxi Griffin is a new contract manufacturer in China with Western management style and quality standards.01.16.18
-
Biologics, Proteins, Vaccines | Biosimilars
Major Changes for Bio Supply Forecast in 2018
Integration of supply chain a critical issue as industry globalizesOnline Exclusives01.12.18
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Drug Development | Industry News | Trials & Filings
Biocon and Mylan Receive ANVISA Approval
For the first biosimilar Trastuzumab to be approved in Brazil01.02.18
-
Bio News | Biosimilars | Drug Development | Industry News
-
Bio News | Biosimilars | Breaking News | Clinical Trials | Industry News | Trials & Filings
Clover Receives CTA Approval For Enbrel Biosimilar
The CFDA's approval is for SCB-808, for the treatment of rheumatoid arthritis12.29.17
-
Bio News | Biosimilars | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Selexis SA and Turgut Pharmaceuticals Expand Agreement
The expanded partnership adds onto the two existing commercial license agreements between the companies12.20.17
-
Bio News | Biosimilars | Breaking News | Drug Development | Industry News
FDA Approves Sanofi's Admelog
This is the first follow-on mealtime insulin ever approved by the FDA12.12.17
